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had when caring for individuals with cyanotic heart disease 
to pursue evaluation of these tumors. CASE: A 23-year-old 
man with a chief complaint of diffuse abdominal pain was 
found to have a 2.6 x 2.8 cm smoothly marginated soft tissue 
mass in the right lower quadrant on abdominal computed 
tomography. Patient had a known history of hypoplastic 
left heart syndrome (mitral atresia-aortic atresia) who 
had undergone a three-stage Norwood repair in child-
hood. In his adulthood was diagnosed with Central Adrenal 
Insuficiency, and Type 2 Diabetes Mellitus. At the time of 
presentation patient was short of breath, tachycardic (heart 
rate 115), and tender to palpation of his right lower quad-
rant. Plasma normetanephrines were 3.8 nmol/L (normal < 
0.9 nmol/L), 24-hour urinary excretion of normetanephrine 
was 1117 mcg/24h (normal 103-390 mcg/24h). Plasma 
metanephrine levels were normal. A  nuclear medicine 
whole body scan with metaiodobenzylguanidine (MIBG) 
scan conirmed a MIBG avid tumor in the right lower quad-
rant. Preoperative management was initiated with oral 
doxazosin. He underwent laparoscopic surgery with re-
moval of a 3 cm pelvis mass resected from the retroperito-
neal tissue deep to the peritoneum along the gonadal vein 
and ureter. Final pathology conirmed the diagnosis of a 
paraganglioma. Postoperatively, plasma normetanephrines 
were corrected at 0.86 nmol/L. Patient underwent genetic 
testing that was negative for FH, MAX, MEN1, NF1, RET, 
SDHA, SDHAF2, SDHB, SDHC, SDHD, TMEM127 and 
VHL. CONCLUSION: Multidisciplinary approach to these 
patients is essential given their complex hemodynamics. 
Long term follow up is necessary to monitor for tumor re-
currence, review of case reports may suggest a higher risk 
of recurrence [1]. Of these case reports there has been no 
strong genetic association found, the most popular theory 
is a causal relationship from their cyanotic heart disease. 
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Background
Long-term glucocorticoid (GC) therapy is commonly used 
to treat rheumatological conditions. This may result in ter-
tiary adrenal insuficiency, as a result of suppression of the 
HPA axis, when GC doses are weaned/withdrawn. There 
is little published data about tertiary adrenal insuficiency 
in this group. This study aims to further evaluate preva-
lence, characteristics and recovery of adrenal insuficiency 
in these patients at a large UK teaching hospital.
Methods
We retrospectively identiied patients seen in outpatient 
clinics between January 2014 and September 2019 who 
had received tapering doses of long-term GC to treat their 
underlying condition (largely patients with polymyalgia 
rheumatica, giant cell arteritis or other vasculitis) and had 
either had a 9am cortisol or short synacthen test (SST). 
Data were collected using a standardised proforma.
Results
There was a total of 238 patients, median age of 71 years 
with a female preponderance (75%). Mean duration of glu-
cocorticoid use was 63.3 months. Mean peak dose of gluco-
corticoid was 29.2mg.
142 patients had 9am cortisol as the irst line test to as-
sess adrenal function. 65% of these were considered sub-
optimal based on local protocol (cortisol <350nmol/L). 38% 
of these patients went on to have SST, of which 56% con-
tinued to show evidence of sub-optimal cortisol production. 
All patients where baseline 9am cortisol was <100nmol/L 
failed to reach stimulated cortisol of >500nmol/L on SST, 
whereas 31% failed SST if 9am cortisol was 250-350 nmol/L.
In total 138 SSTs were performed of which 51% (n=70) were 
abnormal (cortisol <500nmol/L post synacthen). When 
baseline cortisol was <100nmol/L on SST, all patients had 
a suboptimal peak response. However, where baseline cor-
tisol on SST was >350 nmol/L only 3% had a sub-optimal 
peak cortisol.
32 of these patients with an abnormal baseline SST went on 
to have a repeat SST within 2 years. 50% (n=16) continued 
to be suboptimal. Of the 32 patients, 38% (n=12) were 
switched to hydrocortisone with 33% showing complete ad-
renal recovery, average time to recovery of 25 months. 62% 
(n=20) patients did not switch, with 60% demonstrating re-
covery within the same time period (p=0.05). Mean ACTH 
levels in patients who had sub-optimal SST were 23.1 ng/L 
(n=19). ACTH levels were not different between those who 
recovered and those who did not (p=0.23).
Conclusion
Our study suggests that tertiary adrenal insuficiency is 
highly prevalent in this cohort of patients with rheuma-
tological conditions requiring long-term glucocorticoid 
therapy. A 9am cortisol threshold of greater than 350nmol/L 
excludes most patients with adrenal insuficiency. These 
data also suggest no signiicant difference in adrenal re-
covery if switched to hydrocortisone versus continuing 
on prednisolone. ACTH levels were not fully suppressed 
in patients with adrenal insuficiency and did not predict 
recovery.
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Background Previous meta-analyses have reported an in-
crease in the risk of hip fractures in diabetes, but the risk of 
non-vertebral fractures has not been investigated. In addi-
tion, it is not known how the risk of fractures is affected by 
age, body mass index, diabetes duration and insulin use. To 
investigate these features, we conducted a meta-analysis 
on the risk of hip and non-vertebral fractures in diabetes. 
MethodsWe selected a previously published review to be 
updated. Medline, Embase and Cochrane databases were 
searched in March 2018 and an update conducted in March 
2019 (Pubmed) using relevant MeSH and free text terms 
such as “diabetes”, “hyperglycaemia” and “fracture”. We 
selected observational studies with data on the risk of 
fractures in adults ολδερ τηαν 18 years old with diabetes 
compared to people without diabetes. Study quality was 
assessed using the Newcastle Ottawa Scale. We used the 
random-effects model to calculate the risk estimates and 
95% conidence intervals.Results Forty-nine studies were 
included. Forty-three studies were included in the hip 
fracture analysis, 40 cohorts and 3 case-control studies, 
reporting data from 17,575,873 participants, 2,387,899 
with diabetes and 321,720 fractures. Eighteen studies re-
ported the risk of fractures in two or more sites and were 
included in the non-vertebral fracture risk analysis. All but 
one study were cohorts. These studies reported data from 
2,982,622 participants, 414,195 with diabetes and 185,363 
fractures. In both analyses, age varies from 20 to 100 years 
old, including both type 1 and type 2 diabetes. Overall, the 
study quality was judged to be moderate to good.We found 
a signiicant increase in the risk of fracture in diabetes both 
for hip (RR 1.52, 95% CI 1.42-1.63) and for non-vertebral 
fracture (RR 1.20, 1.14-1.27). The increase in the risk was 
greater for insulin users and longer duration of diabetes, at 
both sites. At the hip, the risk was higher in the younger pop-
ulation, women, and those with T1D. ConclusionThere was 
an increase in the risk of hip and non-vertebral fractures 
in diabetes. Although the mechanisms are not established, 
patients with type 1 diabetes were the population at higher 
relative risk. The evidence suggest that the skeleton should 
be considered a site for diabetic complications.
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Context. Determining the free or bioavailable testosterone 
level has gained increasing interest over the years and dif-
ferent indirect algorithms have been suggested.
Objective. To compare commonly used algorithms of 
calculation of serum free testosterone, speciically free 
androgen index (FAI), free testosterone estimated using the 
Vermeulen algorithm (cFTV) and the Zakharov algorithm 
(cFTZ) as well as total testosterone in relation to baseline 
and long-term cardiometabolic conditions.
Design. A  prospective cohort study of men participating 
in four independent population-based surveys (MONICA 
I-III and Inter99) from 1982 to 2001 and followed until 
December 2012 with baseline and follow-up information on 
cardiometabolic parameters.
Setting and Participants. 5350 randomly selected men 
from the general population aged 30, 40, 50, 60, or 70 years 
at baseline participated.
Main Outcome Measures. Baseline cardiometabolic 
parameters and follow-up information on type 2 diabetes, 
ischemic heart disease, cardiovascular disease mortality, 
and all-cause mortality.
Results. Free testosterone levels calculated according to 
the two algorithms differed systematically but however 
correlated well (cFTV vs. cFTZ: r=0.9, p<0.01) and the rel-
ative standard deviations ranged from 37% to 41%. In ge-
neral, men having cardiometabolic conditions at baseline 
had lower absolute levels of FAI, cFTV and cFTZ. However, 
when age-standardizing the hormone levels, FAI levels 
were higher in this group of men whereas cFTV and cFTZ 
remained lower compared to men without these conditions. 
The associations seen for cFTV and cFTZ were in line with 
the association seen for total testosterone. Cox proportional 
hazard models revealed that men in the highest quartiles 
of cFTV or cFTZ had lower risk of developing type 2 di-
abetes (cFTV: HR=0.74 (0.49-1.10), cFTZ: HR=0.59 (0.39-
0.91)) than men in the lowest quartile. In contrast, men 
with highest levels of FAI had a 74% increased risk of de-
veloping type 2 diabetes compared to men in the lowest 
quartile (HR=1.74, 95% CI:1.17-2.59). In relation to all-
cause mortality, FAI showed the strongest inverse associa-
tion followed by cFTV, whereas cFTZ and total testosterone 
did not show any association.
Conclusion. Free testosterone estimated by the Vermeulen 
and Zakharov algorithms differed systematically. However, 
the computed values correlated well and showed similar 
associations to baseline and long-term cardiometabolic 
parameters; albeit with subtle differences. In contrast, an 
empiric ratio, FAI showed opposite associations to several 
of the examined parameters and may relect limited clinical 
utility.
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